Antazoline in the treatment of cardiac arrhythmias.
Antazoline was administered in sixty-five episodes of various types of cardiac arrhythmia. A complete suppression of the ectopic beats was achieved in five out of six episodes of premature atrial systoles and in twenty-one of the twenty-four episodes of ventricular premature systoles. Conversion to sinus rhythm was observed in seven out of ten and four out of five episodes of paroxysmal atrial and nodal tachycardia respectively. Six out of ten episodes of ventricular tachycardia were controlled by intravenous therapy. However, the drug proved to be ineffective in cases of atrial fibrillation. The side-effects were few and transitory, consisting of nausea, vomiting and drowsiness.
Shah
S S
SS
M. P. Shah Medical College and Irwin Group of Hospitals, Jamnagar, Gujarat State, India.
Vaidya
C H
CH
Doshi
H V
HV
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000865:Antazoline / Q000008:administration & dosage*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D055815:Young Adult
D000889:Anti-Arrhythmia Agents; D000865:Antazoline